Expert Interview
A look at the P2 data presented at the American Academy of Dermatology Annual Meeting of Incyte's Opzelura in adult patients with hidradenitis suppurativa.
Ticker(s): INCYInstitution: Dermaclinique
- Board-Certified Dermatologist in Private Practice and Medical Director of Dermatology at Premier Research, a CRO.
- Treats 250 patients for Hidradenitis suppurativa
- Clinical and research interest in systemic agents such as Biologics, JAK inhibitors, and Immunosuppressants with Phase I-IV clinical trial experience in dermatology
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
